What is the ideal SDR-to-AE ratio for a physical therapy software company in 2027?

Segment and ICP first

The ratio question is unanswerable until you name who you sell to, because "physical therapy software" spans at least four buying segments that behave nothing alike. Get this wrong and you will staff a prospecting engine for a market that doesn't need prospecting, or starve a market that does.

Single-clinic owner-operator. One to three treatment tables, the owner is the PT, the office manager, and the buyer. Deal sizes here typically land in the low four figures annually — a practice-management or EMR seat bundle. Sales cycles run two to six weeks. The buyer is nearly impossible to reach by phone during clinic hours because they are literally in a treatment room with a patient. This segment rewards asynchronous, high-volume outbound: email sequences, texts timed to lunch breaks and after 6 p.m., and heavy inbound capture from search and peer referral. An AE here can close 12 to 25 deals a month if pipeline exists, and the constraint is almost never AE capacity — it is reachable, qualified conversations. Ratios skew toward 1:1 or even 1.5 SDRs per AE, but only if the list is large enough to sustain it.

Multi-site group practice (4 to 40 clinics). Now there is a regional director of operations, a billing lead, and often a private-equity-backed platform CFO in the loop. ACVs move into the $25k to $150k range depending on seat count and whether you're selling the EMR of record or a bolt-on. Cycles stretch to three to seven months, with a security review, a data-migration scoping call, and at least one reference visit. AEs carry 15 to 30 open opportunities and need maybe six to ten new qualified meetings a month to stay full. This is the sweet spot for a 1:2 or 1:2.5 ratio — the SDR earns their seat because reaching a multi-site ops director takes eight to twelve touches across three channels, and you do not want a $180k-OTE closer doing that work.

Enterprise and health-system rehab departments. Hospital outpatient rehab, IDN-owned therapy networks, large PE platforms with 100+ locations. Six-figure to seven-figure contracts, 9 to 18 month cycles, formal RFPs, Epic or Cerner integration requirements, and a procurement gauntlet. The prospecting motion here is not SDR work at all — it is executive relationship-building, conference presence, and analyst/consultant influence. Named-account AEs prospect their own logos because the credibility gap between an SDR and a health-system VP of Rehab Services is unbridgeable. Ratio: 1 SDR per 4 to 6 AEs, and the SDR functions more as a research-and-orchestration resource than a dialer.

Adjacent buyers you will be tempted to chase. Chiropractic, occupational therapy, speech-language pathology, and hand therapy clinics run on similar workflows and often the same software. Athletic training rooms at colleges and high schools are a real but low-ACV adjacency. Home-health therapy agencies look adjacent but have entirely different regulatory and billing mechanics (OASIS, PDGM) that will eat your roadmap if you say yes casually. If your ICP genuinely spans PT + OT + SLP outpatient, your list size roughly triples, which materially changes the ratio math in favor of more SDRs.

Write down which of these four is 70% of your revenue plan. That segment sets your baseline ratio; the others get exception handling.

The motion that fits that segment

Ratio follows motion. The mechanical question is: how many qualified opportunities does one AE need per month to hit quota, and how many of those can the AE self-source versus needing an SDR to manufacture?

Run the arithmetic explicitly. Say a mid-market AE carries $600k in annual quota at a $40k average contract value — that's 15 closed-won deals a year, or 1.25 a month. At a 22% opportunity-to-close rate, they need roughly 5.7 new qualified opportunities per month, call it 6. If inbound and partner referral reliably supply 2, and the AE self-sources 1.5 from their own base and network, the SDR needs to produce about 2.5 net-new qualified opportunities per AE per month.

Now flip to the SDR side. A competent SDR working a therapy-clinic list in 2027 — with sequencing tooling, conversational AI dialers doing first-touch triage, and enriched intent data — produces somewhere between 8 and 14 qualified opportunities a month. Divide: 10 opportunities ÷ 2.5 needed per AE = 4 AEs per SDR. That math argues for a *thin* SDR layer, roughly 1:3 or 1:4.

But that clean number almost never survives contact with reality, for three reasons specific to this market. First, therapy-clinic contact data decays fast — practices merge, get acquired by PE rollups, or close, and your list rots at maybe 25-30% a year. SDRs spend real hours on data hygiene that doesn't show up as meetings. Second, qualification standards in healthcare software are strict: a "meeting" with a front-desk coordinator who cannot spell "budget" is not an opportunity, and honest SDR teams disqualify aggressively. Third, seasonality is brutal — nobody buys an EMR in December, and January through March is when practices actually switch systems because they want a clean fiscal or benefit-year cutover.

Apply those frictions and effective SDR output drops to 6 to 9 real opportunities a month. The ratio compresses to 1:2 or 1:2.5, which is where most healthcare-vertical SaaS companies of this shape actually land.

The decision path above is worth walking annually, not once. A company that starts single-clinic and moves upmarket into PE-backed groups will find its correct ratio drifting from 1:1 toward 1:3 over about eighteen months, and the org chart usually lags that drift by two or three quarters.

Unit economics and benchmarks

The ratio is fundamentally a cost-of-pipeline decision, so price it out.

Fully loaded costs, 2027 U.S. market. An SDR runs roughly $65k to $85k base with $85k to $110k OTE, plus tooling, management overhead, and benefits — call it $130k to $155k fully loaded. A mid-market AE sits at $90k to $120k base, $180k to $240k OTE, fully loaded around $250k to $290k. An SDR manager covers 6 to 8 reps at roughly $200k loaded.

What each SDR must return. At $145k loaded and 8 qualified opportunities a month, that's 96 opportunities a year at about $1,510 apiece in SDR cost alone. At a 22% close rate and $40k ACV, those 96 opportunities become 21 deals worth $845k in new ACV. SDR cost as a percentage of sourced revenue: roughly 17%. That is acceptable — you generally want SDR-sourced pipeline costing under 20% of the revenue it produces, and ideally closer to 12-15% once the team matures past its first year.

The CAC payback check. If your blended CAC payback is running past 24 months, adding SDRs makes it worse before it makes it better, because a new SDR is unproductive for their first 60 to 90 days and produces at maybe 60% of steady-state through month six. Budget a $40k to $50k productivity gap per new SDR hire in year one. In a market where your revenue per customer is $40k and gross margin is 78%, that gap is roughly one extra closed deal you had to fund.

Meeting-to-opportunity conversion as the real gate. Track the ratio of SDR-set meetings that survive to a stage-2 qualified opportunity. Healthy healthcare-vertical teams see 55% to 70%. Below 45%, adding SDRs adds noise, not pipeline, and AEs start no-showing SDR meetings — which is the beginning of the death spiral where reps stop trusting the top of the funnel.

Coverage math sanity check. Your ratio should produce 3x to 4x pipeline coverage against quota. If a $600k-quota AE is sitting on $1.4M of pipeline, they are undersupplied and the SDR layer is too thin. If they are sitting on $3.5M, the SDR team is manufacturing volume the AE cannot work, and you are paying twice — once to create the opportunity, once in the AE's attention tax as it ages out. Coverage above 5x is a staffing signal, not a victory.

Total addressable market as a hard ceiling. This is the constraint most companies miss. Estimate the number of outpatient therapy practices you can legitimately sell to, subtract the ones locked into multi-year contracts with an incumbent, and divide by your team's annual touch capacity. If four SDRs can meaningfully work your entire named list in seven months, hiring a fifth doesn't create pipeline — it creates prospect fatigue and burns goodwill in a market where clinic owners talk to each other constantly at state APTA chapter meetings.

Common misfires

Hiring SDRs to fix an AE problem. The most common failure. Quota attainment drops, leadership adds SDR headcount, and six months later attainment is flat while cost of sale is up 15%. If AE win rates are below 18% or average cycles are stretching without a market explanation, the problem is downstream — demo quality, pricing, implementation fear, or a product gap in billing or scheduling that competitors don't have. Adding pipeline to a leaky funnel just makes the leak louder.

Ignoring that clinicians are unreachable during business hours. A PT is with a patient from 7 a.m. to 6 p.m. Standard 9-to-5 SDR calling blocks produce voicemail and irritated front-desk staff. Teams that win here shift coverage: early-morning blocks before first appointments, a lunch window, and a 6-to-8 p.m. block two nights a week. This changes the staffing model more than the ratio does — you may need fewer SDRs working better hours rather than more SDRs working the wrong ones.

Letting SDRs qualify on the wrong signal. "Are you interested in a better EMR?" is not qualification. The signals that predict a closed deal in this market are: current contract end date, whether they are in-network with the payers your billing module supports, patient-visit volume per week, number of licensed clinicians, and whether they've already switched systems once (a practice that has migrated before is dramatically easier to migrate again). Build the qualification framework around those, and your meeting-to-opportunity rate climbs without changing headcount.

Treating the ratio as a fixed org-chart number. Ratios are seasonal in this market. Q4 is a prospecting quarter — clinics are planning next-year budgets and switching decisions. Q1 is an implementation and closing quarter. Some teams run a flexed model: SDRs shift into customer-onboarding support or expansion outreach during the January-to-March crunch, then back to net-new prospecting in Q2. That effectively gives you a 1:2 ratio in Q4 and a 1:3 in Q1 without hiring or firing anyone.

Underestimating what AI-assisted prospecting changed by 2027. Research, list building, personalization drafting, and first-touch triage are largely automated now. The human SDR's differentiated work is the live conversation, the objection about switching cost, and the multi-threading into a group practice's ops and billing leads. Teams that kept the old ratio while adopting the tooling are overstaffed at the top; teams that cut SDRs entirely discovered that automated outreach into a small, tight-knit vertical produces a measurable backlash. The stable answer has been fewer, more senior SDRs — often re-titled as business development reps with real product knowledge — at a leaner ratio than 2022-era playbooks assumed.

Compensating SDRs on meetings set rather than pipeline that survives. Pay on meetings and you get meetings. Pay 40% on meetings held and 60% on opportunities that reach stage 2 or beyond, and the whole system self-corrects within a quarter.

Operating model and cadence

Set the ratio, then build the operating rhythm that lets you detect when it's wrong — usually within six weeks rather than two quarters.

Territory design. Split by geography and practice-count band, not alphabetically. A pod of one SDR and two AEs covering, say, the Southeast with 4-to-20-clinic groups develops real domain fluency — they learn which state Medicaid rules matter, which regional PE platforms are rolling up practices, and which competitor is losing accounts. Pods beat pooled models in vertical software because the vocabulary is specific and reputation compounds locally.

Weekly cadence. Monday: pod stand-up reviewing last week's meetings held, opportunities created, and the disqualification reasons. Wednesday: pipeline inspection on stage-2-and-later deals only. Friday: list review — what got added, what got scrubbed, which accounts are going dormant. That Friday meeting is the one most teams skip and the one that keeps the ratio honest, because list exhaustion shows up in list review months before it shows up in meeting counts.

The metrics that actually trigger a ratio change. Four numbers, reviewed monthly. (1) Qualified opportunities per SDR per month — if it's been under 6 for two consecutive months and it isn't a ramp issue, your list is thin or your ICP is wrong, not your SDR count. (2) Percentage of AE pipeline that is SDR-sourced — under 30% means the SDR layer isn't earning its keep; over 70% means AEs have stopped prospecting entirely, which is fragile. (3) Pipeline coverage per AE, held between 3x and 4x. (4) Days-to-first-touch on inbound, held under 10 minutes during business hours — inbound in this vertical converts three to five times better than outbound and should never queue behind cold calling.

Ramp and hiring sequencing. Hire SDRs in pairs, not singly — a lone new SDR has no peer to compare notes with and ramps slower. Hire the SDR *before* the AE when moving upmarket, because it takes 90 days to build the pipeline the new AE will need on day one. Hire the AE first when you're SMB-heavy and inbound is already backing up.

Where the adjacent functions absorb pressure. A strong solutions-consultant or implementation-preview resource can lift AE capacity by 20-30% in healthcare software, because the fear that kills these deals is migration risk, not price. Adding one SC per four or five AEs often produces more incremental revenue than adding two SDRs. Similarly, a customer-marketing motion that turns existing clinic owners into referrers can supply 15-25% of pipeline in a tight vertical — cheaper per opportunity than any SDR, and it converts faster.

A note on what happens after the ratio is right. The teams that sustain efficient growth in vertical healthcare software eventually stop optimizing the SDR-to-AE ratio and start optimizing the ratio of *sourced* to *unsourced* pipeline — outbound versus inbound, partner, and expansion. In a market with a countable number of buyers, the long-run winner is usually the company whose product and reputation generate demand, with a lean outbound team working the accounts that reputation hasn't reached yet.

Related questions

How does the ratio change if we sell to chiropractic and OT clinics too?

Broadening to OT, chiro, and speech-language practices roughly triples your list size without changing deal mechanics much. That extra runway supports a richer SDR layer — often shifting from 1:2.5 toward 1:1.5 — provided your product genuinely handles each discipline's documentation and billing codes.

Should our first sales hire be an SDR or an AE?

An AE, almost always. Your first closer needs to run the full cycle to learn where deals die. Add the SDR once that AE is spending more than a third of their week prospecting and inbound alone can't fill the calendar — typically around $400k to $600k in annual run rate.

What SDR-to-AE ratio do PE-backed rollups expect to see?

Sponsors typically press for magic number and CAC payback targets rather than a headcount ratio. Show SDR-sourced pipeline costing under 20% of the revenue it generates and a payback under 18 months, and the ratio itself rarely gets challenged.

How many meetings should an SDR set per month in healthcare software?

Fifteen to twenty-two meetings held, converting to 8 to 14 qualified opportunities. Below that range, check list quality and calling hours before questioning the rep. Healthcare verticals run lower volume and higher qualification rigor than horizontal SaaS.

Does an AI SDR replace the ratio question entirely?

No. Automated tooling absorbs research, sequencing, and first-touch triage, which lets each human SDR cover more accounts. It does not handle the switching-cost objection or multi-thread a group practice. The ratio widens; it doesn't disappear.

FAQ

What is the single biggest determinant of the right ratio?

Average contract value, because it dictates how many deals an AE must close and therefore how much pipeline they consume. A $5k ACV business needs volume and leans toward 1:1. A $200k ACV business needs precision and leans toward 1:5. Everything else — cycle length, market size, channel mix — modifies that baseline rather than setting it.

How long should we run a new ratio before judging it?

Two full sales cycles, minimum. In multi-site therapy software that's roughly nine to twelve months. Judging a ratio at 90 days measures ramp, not effectiveness, and teams that reorganize quarterly never let any model produce clean data.

Do we need SDRs at all if inbound is strong?

Possibly not, early on. If inbound supplies 4-plus qualified opportunities per AE per month and your AEs are at capacity, spend the marginal dollar on marketing and a solutions consultant instead. Add outbound when you need to reach specific named accounts inbound will never touch — usually the multi-site groups with an incumbent vendor.

Should SDRs report to sales or marketing?

To sales, in a vertical this narrow. The feedback loop between what SDRs hear on calls and how AEs handle switching-cost objections is the most valuable thing the team produces, and it degrades when the two functions sit in different orgs with different metrics.

What's a realistic SDR-to-AE ratio for a seed-stage company?

Zero to one SDR total, supporting two founding AEs, and often the founder is still selling. Before roughly $2M ARR, the highest-leverage prospecting is founder-led outreach into a hand-built list. Formalize the SDR function once the motion is repeatable and you can write down what a qualified opportunity is.

How do payer mix and billing complexity affect the ratio?

Heavily. If your product's differentiation is billing and payer-contract handling, qualification requires knowing a practice's payer mix — which is slower, more technical discovery. That pushes toward fewer, more senior SDRs, effectively widening the ratio while raising per-rep cost.

Sources

• https://www.saastr.com/
• https://openviewpartners.com/blog/
• https://www.bridgegroupinc.com/research
• https://www.gartner.com/en/sales
• https://hbr.org/topic/subject/sales
• https://www.apta.org/
• https://www.mckinsey.com/capabilities/growth-marketing-and-sales/our-insights
• https://www.bain.com/insights/topics/technology/
• https://www.bls.gov/ooh/healthcare/physical-therapists.htm

Related on PULSE

• How to size a sales territory in vertical healthcare software
• Building a qualification framework for clinical software buyers
• When to hire your first solutions consultant
• Pipeline coverage benchmarks by average contract value
• Inbound versus outbound mix in narrow vertical markets
• Comp plan design for SDRs paid on qualified pipeline